Deczuba 50 (Decitabine) 50mg

Deczuba 50 contains decitabine 50mg, a chemotherapy medication used in cancer treatment. This injectable form is prescribed for certain blood cancers. Store between 15–25°C to maintain potency. Always follow healthcare provider instructions.

Strength

50mg

Pack Size

Storage

15 -25ºC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Deczuba 50 is used to treat myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). It works by slowing or stopping the growth of cancer cells in the bone marrow. Decitabine is often prescribed when other treatments are not suitable. Patients may hear it referred to as a hypomethylating agent.

Side Effects

Deczuba 50 may help reduce symptoms related to blood disorders by supporting normal blood cell production. Some patients report improved energy levels and reduced infections during treatment. Effects vary based on individual health and condition. Regular monitoring by a healthcare provider is recommended.

Precautions & Warnings

Keep Deczuba 50 in its original packaging until ready to use. Protect from light and moisture. Avoid handling if pregnant or breastfeeding. Use only as directed by a healthcare professional. Discard any unused solution properly according to local guidelines.

Avoid Interactions

Deczuba 50 may interact with other medications that affect the bone marrow or immune system. Avoid live vaccines during treatment. Certain drugs, like strong CYP inhibitors, can alter decitabine levels. Always inform your doctor about all medications, supplements, or herbal products you are using.

Frequently Asked Questions

Deczuba 50 is used to treat certain types of blood cancers, including myelodysplastic syndromes and acute myeloid leukemia.

Store Deczuba 50 between 15–25°C in its original packaging and protect it from light and moisture.

Always consult your doctor before taking Deczuba 50 with other medications, as interactions may occur.

Contact your healthcare provider for guidance if a dose is missed. Do not take extra doses without professional advice.

Deczuba 50 should not be used during pregnancy unless specifically directed by a doctor due to potential risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.